Intracranial Pressure (ICP) Monitoring Market Growth
Intracranial pressure (ICP) monitoring devices market is expected to witness substantial growth over the forecast period (from 2014 to 2025)
Intracranial pressure measurements are important in the treatment and evaluation of neurological diseases such as intracerebral (ICH) hemorrhage, subarachnoid hemorrhage (SAH), hydrocephalus, traumatic brain injury (TBI), encephalitis/meningitis, and ischemic stroke. The global intracranial pressure (ICP) monitoring devices market is expected at USD 1.9 billion by 2025, according to a report by Grand View Research, Inc. This growth can be attributed to the rising neurological ailments and awareness about the treatments available for these ailments. In addition, extensive research funding and high disease occurrences together are likely to impact the market growth positively. However, the high price associated with the advanced ICP monitoring devices along with the lack of expert professionals in the upcoming regions is one of the major factors that may hamper the growth of the global industry.
There are a number of products available to efficiently carrying out the operations of the ICP monitoring device such as Integra Neuroscience Products. The Integra Neuroscience external drainage catheter is a Cerebrospinal Fluid (CSF) diversion system. This device is instrumental in evaluating the ICP. It has transparent catheter tubing with depth markings and includes a strip of radio-opaque barium sulfite. Intracranial pressure readings are based on a transduction system that is fluid-filled and puts out the ICP changes through a tube (saline-filled) to a diaphragm placed on strain gauge transducer. After insertion, this monitoring device has to be leveled with Foreman of Monro (the External Auditory Canal’s (EAC) level) and must be zero-balanced every day. The level of the drain is adjustable in order to allow less or more CSF drainage.
The global intracranial pressure (ICP) monitoring devices market is expected to witness substantial growth over the forecast period (from 2014 to 2025). The growing number of patients suffering from severe neurological disorders that can cause high intracranial pressure is said to drive the growth of the global industry over the next few years. The major intracranial pressure monitoring devices manufacturers are Codman & Shurtleff, Inc.; RAUMEDIC AG.; and Integra LifeSciences Holdings Corp. All these key companies are present globally and—due to trouble-free accessibility to the international market—are now competing with each other in order to achieve greater industry share.
In-Depth research report on intracranial pressure monitoring devices market: